Skip to main content

CytomX Therapeutics, Inc.

CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001501989

No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in CytomX Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
69
−3 vs. Q2 2024
Shares held
51.2M
+1.70M (+3.4%) vs. Q2 2024
Total value
$60.4M
+$19.8K (0.0%) vs. Q2 2024
New holders
10
18 more added
Sold out
13
23 more reduced

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CTMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 69 institutions
Q1 2021: 126 institutionsQ2 2021: 122 institutionsQ3 2021: 114 institutionsQ4 2021: 110 institutionsQ1 2022: 119 institutionsQ2 2022: 99 institutionsQ3 2022: 84 institutionsQ4 2022: 81 institutionsQ1 2023: 76 institutionsQ2 2023: 67 institutionsQ3 2023: 62 institutionsQ4 2023: 68 institutionsQ1 2024: 88 institutionsQ2 2024: 74 institutionsQ3 2024: 69 institutionsQ4 2024: 70 institutionsQ1 2025: 66 institutionsQ2 2025: 83 institutionsQ3 2025: 103 institutionsQ4 2025: 122 institutionsQ1 2026: 179 institutionsQ2 2026: 178 institutions
Value heldQ3 2024: $60.4M
Q1 2021: $422.2MQ2 2021: $358.9MQ3 2021: $274.8MQ4 2021: $236.5MQ1 2022: $143.4MQ2 2022: $83.4MQ3 2022: $52.6MQ4 2022: $57.5MQ1 2023: $53.7MQ2 2023: $58.7MQ3 2023: $41.8MQ4 2023: $50.6MQ1 2024: $97.1MQ2 2024: $61.9MQ3 2024: $60.4MQ4 2024: $48.1MQ1 2025: $28.8MQ2 2025: $302.6MQ3 2025: $438.4MQ4 2025: $613.9MQ1 2026: $911.2MQ2 2026: $799.0M
Institutions holding CTMX and their total value by quarter
QuarterHoldersValue
Q2 2026178$799.0M
Q1 2026179$911.2M
Q4 2025122$613.9M
Q3 2025103$438.4M
Q2 202583$302.6M
Q1 202566$28.8M
Q4 202470$48.1M
Q3 202469$60.4M
Q2 202474$61.9M
Q1 202488$97.1M
Q4 202368$50.6M
Q3 202362$41.8M
Q2 202367$58.7M
Q1 202376$53.7M
Q4 202281$57.5M
Q3 202284$52.6M
Q2 202299$83.4M
Q1 2022119$143.4M
Q4 2021110$236.5M
Q3 2021114$274.8M
Q2 2021122$358.9M
Q1 2021126$422.2M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding CytomX Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding CTMX in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Federated Hermes, Inc.117$1380.00%00.0%Unchanged
BNP Paribas Arbitrage, SA194$2290.00%+116+148.7%Added
Tower Research Capital LLC (TRC)238$2810.00%−16,801−98.6%Reduced
Raleigh Capital Management Inc.250$2950.00%00.0%Unchanged
JPMorgan Chase & Co281$3320.00%00.0%Unchanged
Bollard Group LLC712$1.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.900$1.06K0.00%00.0%Unchanged
Group One Trading, L.P.4,911$5.79K0.00%−12,053−71.1%Reduced
Lazard Asset Management LLC8,828$10.0K0.00%−9,653−52.2%Reduced
Ikarian Capital, LLC8,924$10.5K0.00%00.0%Unchanged
Peregrine Asset Advisers, Inc.10,000$11.8K0.00%+10,000New
Susquehanna International Group, LLP10,304$12.2K0.00%−15,615−60.2%Reduced
EP Wealth Advisors, LLC10,432$12.3K0.00%+10,432New
Goldman Sachs Group Inc12,000$14.2K0.00%−97,302−89.0%Reduced
IPG Investment Advisors LLC12,500$14.8K0.00%00.0%Unchanged
Nierenberg Investment Management Company, Inc.12,555$14.8K0.01%00.0%Unchanged
WestHill Financial Advisors, Inc.17,082$20.2K0.00%00.0%Unchanged
Bank of America Corp20,561$24.3K0.00%+14,817+258.0%Added
Cubist Systematic Strategies, LLC24,460$28.9K0.00%−57,594−70.2%Reduced
Charles Schwab Investment Management Inc24,817$29.3K0.00%00.0%Unchanged
HRT Financial LP26,840$31.0K0.00%+26,840New
Jane Street Group, LLC27,231$32.1K0.00%−52,470−65.8%Reduced
AJOVista, LLC33,121$39.1K0.17%+33,121New
US Bancorp33,792$39.9K0.00%+33,792New
Prudential Financial Inc36,500$43.1K0.00%00.0%Unchanged
Invesco Ltd.37,464$44.2K0.00%+14,370+62.2%Added
LPL Financial LLC38,315$45.2K0.00%+2,000+5.5%Added
Cornercap Investment Counsel Inc41,458$48.9K0.01%−39,133−48.6%Reduced
XTX Topco Ltd43,664$51.5K0.00%−16,922−27.9%Reduced
Stifel Financial Corp46,100$54.4K0.00%−1,000−2.1%Reduced
Russell Investments Group, Ltd.47,649$56.2K0.00%+4,835+11.3%Added
Morgan Stanley50,368$59.4K0.00%−138,118−73.3%Reduced
Private Advisor Group, LLC52,179$61.6K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC54,243$64.0K0.00%00.0%Unchanged
Qube Research & Technologies Ltd55,108$65.0K0.00%+500+0.9%Added
Forefront Analytics, LLC59,760$70.5K0.03%−4,305−6.7%Reduced
UBS Group AG69,135$81.6K0.00%−1,233−1.8%Reduced
Virtu Financial LLC88,518$104.0K0.01%+88,518New
Creative Planning107,000$126.3K0.00%00.0%Unchanged
Northern Trust Corp129,886$153.3K0.00%−1,141−0.9%Reduced
Bank of New York Mellon Corp241,982$285.5K0.00%00.0%Unchanged
Formidable Asset Management, LLC246,001$290.3K0.05%−12,000−4.7%Reduced
Toroso Investments, LLC246,001$290.3K0.00%−12,000−4.7%Reduced
State Street Corp263,643$311.1K0.00%00.0%Unchanged
Connor, Clark & Lunn Investment Management Ltd.280,593$331.1K0.00%+26,373+10.4%Added
FMR LLC284,307$335.5K0.00%+41,949+17.3%Added
Citadel Advisors LLC317,119$374.2K0.00%−177,524−35.9%Reduced
Bridgeway Capital Management, LLC356,624$420.8K0.01%−12,500−3.4%Reduced
Woodline Partners LP393,832$464.7K0.00%+393,832New
Two Sigma Investments, LP471,468$556.3K0.00%−190,479−28.8%Reduced
SEI Investments Co487,902$575.7K0.00%+105,179+27.5%Added
Geode Capital Management, LLC803,531$948.4K0.00%+34,032+4.4%Added
ADAR1 Capital Management, LLC903,959$1.07M0.18%+331,789+58.0%Added
Altium Capital Management LP915,000$1.08M0.32%+915,000New
Renaissance Technologies LLC1,015,000$1.20M0.00%−168,022−14.2%Reduced
BlackRock, Inc.1,168,566$1.38M0.00%+1,168,566New
Schonfeld Strategic Advisors LLC1,211,800$1.43M0.01%−163,490−11.9%Reduced
Congress Park Capital LLC1,216,008$1.43M0.53%+62,788+5.4%Added
Laurion Capital Management LP1,248,364$1.47M0.09%−278,023−18.2%Reduced
Jacobs Levy Equity Management, Inc1,524,076$1.80M0.01%+16,359+1.1%Added
Assenagon Asset Management S.A.1,644,168$1.94M0.00%+405,669+32.8%Added
Millennium Management LLC2,560,256$3.02M0.00%+714,853+38.7%Added
Adage Capital Partners GP, L.L.C.3,000,000$3.54M0.01%00.0%Unchanged
Prosight Management, LP3,022,109$3.57M0.90%+3,022,109New
Acadian Asset Management LLC3,100,994$3.65M0.01%+372,425+13.6%Added
Janus Henderson Group PLC4,809,518$5.70M0.00%−1,492,465−23.7%Reduced
Vanguard Group Inc5,162,302$6.09M0.00%+270,000+5.5%Added
BVF Inc5,228,461$6.17M0.18%00.0%Unchanged
Tang Capital Management LLC7,811,760$9.22M0.66%+19,824+0.3%Added
RTW Investments, LP0$00.00%−1,200,002−100.0%Sold out
Superstring Capital Management LP0$00.00%−1,151,518−100.0%Sold out
Ghost Tree Capital, LLC0$00.00%−300,000−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−229,093−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−210,027−100.0%Sold out
Squarepoint Ops LLC0$00.00%−198,840−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−158,400−100.0%Sold out
LMR Partners LLP0$00.00%−15,046−100.0%Sold out
Simplex Trading, LLC0$00.00%−3,891−100.0%Sold out
Whittier Trust Co0$00.00%−2,200−100.0%Sold out
Rhumbline Advisers0$00.00%−1,291−100.0%Sold out
Innealta Capital, LLC0$00.00%−2−100.0%Sold out
Royal Bank of Canada0$00.00%−248−100.0%Sold out
BlackRock Inc.––––Not filed
Susquehanna Fundamental Investments, LLC––––Not filed